Clinical Trial Update: Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and safety of mirabegron compared with solifenacin for overactive bladder, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)
• Vesicare (solifenacin succinate)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED